In one paragraph
Hawaii's Senate Bill 3027 (2026), which calls itself the Hawaii Patients' Bill of Rights of 2025, would have set prior authorization deadlines for health carriers (one business day urgent, three non-urgent) and required written disclosure of any automated decision support tool used in utilization review. A board-certified clinician would have had to independently approve any adverse action the tool materially contributed to. It was referred to committee January 30, 2026 and not enacted. It would have taken effect July 1, 2026.
Plain-English summary, written with AI assistance. The official text controls.
What it means for business
None: the bill was not enacted. If enacted, health carriers and utilization review organizations would have faced prior authorization, AI tool disclosure and clinician review duties.
Key provisions
- Would have required carriers to decide urgent prior authorization requests within one business day and others within three, with written notice and appeal information for adverse determinations
- Would have required carriers and utilization review organizations using an automated decision support tool to disclose in each policy how it is used, and carriers to notify enrollees and providers in writing when it materially contributed to an adverse action
- Would have barred such an adverse action until a board-certified clinician independently reviews and approves it, using independent medical judgment
- Would have required carriers to make governance policies, validation and bias-testing processes and monitoring records available for the commissioner's annual review by June 30, 2027, plus monthly reports on tool use to the insurance commissioner, and 72-hour data breach notice
- Would have let the commissioner audit, investigate or penalize carriers, require restitution and seek injunctive relief, with no dollar amounts set
- Introduced January 23, 2026; referred to HHS, CPN/WAM January 30, 2026; stated effective date July 1, 2026
Latest legislative action
Jan 30, 2026. Referred to HHS, CPN/WAM.
Sponsors (showing 5 of 17)
| Name | Role |
|---|---|
| Baker | Primary |
| C. | Primary |
| FEVELLA | Primary |
| Gabbard | Primary |
| Galuteria | Primary |
Topics and industries
Related topics
Affected industries
This page is general information, not legal advice. Summaries are AI-assisted and may contain errors; read the statute for the controlling text and talk to a lawyer about your situation. Full disclaimer · Report an error